Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 158-165

  Singh, Dhruv K ^a   Winocour, Peter ^a   Summerhayes, Bev ^a   Kaniyur, Sunil ^a   Viljoen, Adie ^a   Sivakumar, G ^a   Farrington, Ken ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Osteoprotegerin; Peripheral neuropathy; Progression of calcification; Type 2 diabetes mellitus; Vascular calcification

Indexed keywords

CREATININE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGE; ARTERY CALCIFICATION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE COURSE; DORSAL PEDAL ARTERY; ETHNICITY; FEMALE; FEMORAL ARTERY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LEG ARTERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; POSTERIOR TIBIAL ARTERY; PREDICTION; PREVALENCE; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; FEMORAL ARTERY; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PILOT PROJECTS; PREVALENCE; RISK FACTORS; SMOKING; TIBIAL ARTERIES; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84864111720     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.01.038     Document Type: Article

References (25)

1. Most R.S., Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983, 6(1):87-91.
2. Rubin M.R., Silverberg S.J. Vascular calcification and osteoporosis-the nature of the nexus. J Clin Endocrinol Metab 2004, 89(9):4243-4245.
3. Young M.J., Adams J.E., Anderson G.F., Boulton A.J., Cavanagh P.R. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993, 36(7):615-621.
4. Lehto S., Niskanen L., Suhonen M., Ronnemaa T., Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16(8):978-983.
5. Psyrogiannis A., Kyriazopoulou V., Vagenakis A.G. Medial arterial calcification is frequently found in patients with microalbuminuria. Angiology 1999, 50(12):971-975.
6. Singh D.K., Winocour P., Summerhayes B., Viljoen A., Sivakumar G., Farrington K. Are low erythropoietin and 1,25-dihydroxyvitamin D levels indicative of tubulo-interstitial dysfunction in diabetes without persistent microalbuminuria?. Diabetes Res Clin Pract 2009, 85(3):258-264.
7. Singh D.K., Winocour P., Farrington K. Endothelial cell dysfunction, medial arterial calcification and osteoprotegerin in diabetes. Br J Diab Vasc Dis 2010, 10(2):71-77.
8. Kiel D.P., Kauppila L.I., Cupples L.A., Hannan M.T., O'Donnell C.J., Wilson P.W. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham heart study. Calcif Tissue Int 2001, 68(5):271-276.
9. Schoppet M., Sattler A.M., Schaefer J.R., Herzum M., Maisch B., Hofbauer L.C. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 2003, 88(3):1024-1028.
10. Panizo S., Cardus A., Encinas M., Parisi E., Valcheva P., Lopez-Ongil S., et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 2009, 104(9):1041-1048.
11. Schoppet M., Al-Fakhri N., Franke F.E., Katz N., Barth P.J., Maisch B., et al. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab 2004, 89(8):4104-4112.
12. Ziegler S., Kudlacek S., Luger A., Minar E. Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. Atherosclerosis 2005, 182(1):175-180.
13. Anand D.V., Lahiri A., Lim E., Hopkins D., Corder R. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol 2006, 47(9):1850-1857.
14. Anand D.V., Lim E., Darko D., Bassett P., Hopkins D., Lipkin D., et al. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol 2007, 50(23):2218-2225.
15. Maser R.E., Nielsen V.K., Bass E.B., Manjoo Q., Dorman J.S., Kelsey S.F., et al. Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 1989, 12(4):270-275.
16. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15(4):827-832.
17. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
18. Chiu Y.W., Adler S.G., Budoff M.J., Takasu J., Ashai J., Mehrotra R. Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int 2010, 77(12):1107-1114.
19. Mehrotra R., Budoff M., Christenson P., Ipp E., Takasu J., Gupta A., et al. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int 2004, 66(5):2022-2031.
20. Wagenknecht L.E., Divers J., Bertoni A.G., Langefeld C.D., Carr J.J., Bowden D.W., et al. Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes. Ann Epidemiol 2011, 21(1):34-41.
21. Fox C.S., Larson M.G., Keyes M.J., Levy D., Clouse M.E., Culleton B., et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: The Framingham Heart Study. Kidney Int 2004, 66(5):2017-2021.
22. Annuk M., Zilmer M., Lind L., Linde T., Fellstr+âm B. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001, 12(12):2747-2752.
23. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12(9):1260-1268.
24. Malyankar U.M., Scatena M., Suchland K.L., Yun T.J., Clark E.A., Giachelli C.M. Osteoprotegerin is an alpha vbeta 3-induced NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem 2000, 275(28):20959-20962.
25. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339(4):229-234.